Effects of hydroxylpropyl-β-cyclodextrin on in vitro insulin stability

International Journal of Molecular Sciences

Volumn 10, Issue 5, 2009, Pages 2031-2040

  Zhang, Liefeng ^a   Zhu, Wenjie ^a   Song, Lingling ^a   Wang, Yifan ^a   Jiang, Hui ^a   Xian, Suyun ^a   Ren, Yong ^a  

^a NANJING NORMAL UNIVERSITY   (China)

Author keywords

Cyclodextrin; Insulin; Protection; Stability

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ACID; BASE; INSULIN;

ARTICLE; COMPLEX FORMATION; CYCLOADDITION; DISULFIDE BOND; DRUG ACTIVITY; DRUG DECOMPOSITION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG STABILITY; FLUORESCENCE SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH TEMPERATURE; IN VITRO STUDY; INFRARED SPECTROSCOPY; PROTECTION; PROTON NUCLEAR MAGNETIC RESONANCE;

CYCLODEXTRIN; INSULIN; PROTECTION; STABILITY;

BETA-CYCLODEXTRINS; CYCLODEXTRINS; DRUG STABILITY; HOT TEMPERATURE; HYDROGEN-ION CONCENTRATION; INSULIN; PHARMACEUTICAL PREPARATIONS;

EID: 67049158572     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms10052031     Document Type: Article

References (26)

1. Sanger, F.; Thompson, E.O.P.; Kitai, R. The amide groups of insulin. Biochem. J. 1955, 59, 509-518.
2. Brange, J.; Langkjoer, L. Insulin structure and stability. Pharmacol. Biotechnol. 1993, 5, 315-350.
3. Slobin, L.I.; Carpenter, F.H. The labile amide in insulin: Preparation of desalanine-desamidoinsulin. Biochemistry 1963, 2, 22-28.
4. Fisher, B.V.; Porter, P.B. Stability of bovine insulin. J.Pharm. Pharmacol. 1981, 33, 203-206.
5. Brange, J.; Langkjær, L.; Havelund, S.; VØlund, A. Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparations. Pharm. Res. 1992, 9, 715-726.
6. Li, Z.F.; Wang, M.; Wang, F.; Gu, Z.B.; Du, G.C.; Wu, J.; Chen, J. Gamma-cyclodextrin: A review on enzymatic production and applications. Appl. Microbiol. Biotechnol. 2007, 77, 245-255.
7. Loftsson, T.; Jarho, P.; Masson, M.; Jarvinen, T. Cyclodextrins in drug delivery. Expert Opin. Drug Deliv. 2005, 2, 335-351.
8. Yoshida, A.; Yamamoto, M.; Hirayama, F.; Uekama, K. Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives. Chem. Pharm. Bull. (Tokyo) 1988, 36, 4075-4080.
9. Gould, S.; Scott, R.C. 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): A toxicology review. Food Chem. Toxicol. 2005, 43, 1451-1459.
10. Stella, V.J.; Rajewski, R.A. Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. 1997, 14, 556-567.
11. Sajeesh, S.; Sharma, C.P. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int. J. Pharm. 2006, 325, 147-154.
12. Lovatt, M.; Cooper, A.; Camilleri, P. Energetics of cyclodextrin-induced dissociation of insulin. Eur. Biophys. J. 1996, 24, 354-357.
13. Dotsikas, Y.; Loukas, Y.L. Kinetic degradation study of insulin complexed with methyl-beta cyclodextrin. Confirmation of complexation with electrospray mass spectrometry and H-1 NMR. J. Pharm. Biomed. Anal.2002, 29, 487-494.
14. Shao, Z.; Li, Y.P.; Chermak, T.; Mitra, A.K. Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin. Pharm. Res. 1994, 11, 1174-1179.
15. Zhang, L.F.; Jiang, H.; Zhu, W.J.; Wu, L.; Song, L.L.; Wu, Q.Y.; Ren, Y. Improving the stability of insulin in solutions containing intestinal proteases in vitro. Int. J. Mol. Sci. 2008, 9, 2376-2387.
16. Zhang, Y.; Whittingham, J.L.; Turkenburg, J.P.; Dodson, E.J.; Brange, J.; Dodson, G.G. Crystallization and preliminary crystallographic investigation of a low-pH native insulin monomer with flexible behaviour. Acta Crystallogr. D Biol. Crystallogr. 2002, 58,186-187.
17. Huus, K.; Havelund, S.; Olsen, H.B.; de Weert, M.V.; Frokjaer, S. Chemical and thermal stability of insulin: Effects of zinc and ligand binding to the insulin zinc-hexamer. Pharm. Res. 2006, 23, 2611-2620.
18. Weiss, M.A.; Nguyen, D.T.; Khait, I.; Inouye, K.; Frank, B.H.; Beckage, M.; O'Shea, E.; Shoelson, S.E.; Karplus, M.; Neuringer, L.J. Two-dimensional NMR and photo-CIDNP studies of the insulin monomer: assignment of aromatic resonances with application to protein folding, structure, and dynamics. Biochemistry 1989, 28, 9855-9873.
19. Laemmli, U.K. Cleavage of structural proteins during the assay of the head of bacteriophage T4. Nature 1970, 277, 680-685.
20. Todo, H.; Okamoto, H.; Iida, K.; Danjo, K. Improvement of stability and absorbalility of dry insulin powder for inhalation by powder-combination technique. Int. J. Pharm. 2004, 271, 41-52.
21. Hua, Q.X.; Weiss, M.A. Comparative 2D NMR studies of human insulin and des-pentapeptide insulin: sequential resonance assignment and implications for protein dynamics and receptor recognition. Biochemistry 1991, 30 , 5505-5515.
22. Khafagy, E.S.; Morishita, M.; Onuki, Y.; Takayama, K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv. Drug Deliv. Rev. 2007, 59, 1521-1546.
23. Gere-Paszti, E.; Cserhati, T.; Forgacs, E.; Deyl, Z.; Miksik, I. Interaction of hydroxypropyl-betacyclodextrin with peptides, studied by reversed-phase thin-layer chromatography. J. Liq. Chromatogr. Rel. Technol. 2005, 28, 2619-2632.
24. Hermens, W.A. Delivery of hormones: some new concepts. Pharm. Weekbl. Sci. 1992, 14, 253-257.
25. Irie, T.; Uekama, K. Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev. 1999, 36, 101-123.
26. Banga, A.K.; Mitra, R. Minimization of shaking-induced formation of insoluble aggregates of insulin by cyclodextrins. J. Drug Target. 1993, 1, 341-345.